can i take glp 1 without diabetes GLP-1 Agonists In Obesity GLP-1 Receptor Agonists as Treatments

He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, et al

Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)]

E., El-Kadem, A

In general, prior authorization can be obtained for some of the GLP-1 agonists if you and your healthcare provider can prove they are medically necessary and you meet certain criteria

These doses are typically lower than traditional treatment regimens, potentially ranging from 0.25mg to 0.5mg weekly, aiming for sustained benefits with minimal side effects